HCA Healthcare Stock Movement Summary HCA Healthcare's stock rose 5.84% following the release of Q4 2025 earnings and forward guidance. Key facts: Q4 Results: - Revenue of $19.51 billion, up 6.7% year-over-year, but missed Wall Street estimates - GAAP diluted earnings per share of $8.14, exceeding analyst consensus by 9.2% - Full-year 2025 revenue guidance of $78.25 billion at midpoint came in 1.1% below estimates 2026 Outlook: - Company forecasted 2026 profit above Wall Street expectations - 2026 revenue guidance: $76.5 billion to $80.0 billion - 2026 diluted EPS guidance: $29.10 to $31.50 - Growth driven by strong demand for medical care services and increased Medicare utilization Capital Actions: - Authorized $10 billion share buyback program - Declared quarterly cash dividend of $0.78 per share Analyst Response: - Goldman Sachs raised price
Read full analysisHCA Healthcare Stock Movement Summary HCA Healthcare's stock rose 5.84% following the release of Q4 2025 earnings and forward guidance. Key facts: Q4 Results: - Revenue of $19.51 billion, up 6.7% year-over-year, but missed Wall Street estimates - GAAP diluted earnings per share of $8.14, exceeding analyst consensus by 9.2% - Full-year 2025 revenue guidance of $78.25 billion at midpoint came in 1.1% below estimates 2026 Outlook: - Company forecasted 2026 profit above Wall Street expectations - 2026 revenue guidance: $76.5 billion to $80.0 billion - 2026 diluted EPS guidance: $29.10 to $31.50 - Growth driven by strong demand for medical care services and increased Medicare utilization Capital Actions: - Authorized $10 billion share buyback program - Declared quarterly cash dividend of $0.78 per share Analyst Response: - Goldman Sachs raised price
HCA Healthcare Inc. (HCA) is a publicly traded company in the Healthcare sector.